Bontia, Rebecca L.
HRN: 19-05-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/01/2022
07/07/2022
IVTT
2.25
Q8
CAP Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes